| Dr Edwin Peter Schulhafer, MD | |
|
712 Courtyard Dr, Hillsborough, NJ 08844-4257 | |
| (908) 252-1050 | |
| (908) 252-1055 |
| Full Name | Dr Edwin Peter Schulhafer |
|---|---|
| Gender | Male |
| Speciality | Allergy/immunology |
| Experience | 41 Years |
| Location | 712 Courtyard Dr, Hillsborough, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205886785 | NPI | - | NPPES |
| 4615107 | Medicaid | NJ | |
| 1730120437 | Other | NJ | ORGANIZATION NPI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | 25MA04462800 (New Jersey) | Primary |
| Entity Name | Allergy Asthma & Sinus Center Of Nj Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730120437 PECOS PAC ID: 0547291882 Enrollment ID: O20050825000922 |
News Archive
Everyone knows olive oil and a Mediterranean diet are associated with a lower risk for cardiovascular disease, but a new research report published in the July 2010 print issue of the FASEB Journal offers a surprising reason why: These foods change how genes associated with atherosclerosis function.
UC San Francisco researchers have completed the first Internet-based clinical trial for children with autism, establishing it as a viable and cost effective method of conducting high-quality and rapid clinical trials in this population.
A new study shows that a drug, called daclizumab, is effective at reducing organ rejection and risk of infection in heart transplant patients. The multi-center study by cardiologists from the United States, Sweden, Germany and Canada will be published in the June 30 issue of The New England Journal of Medicine.
A new study has drawn a direct link between the amount of stigma men with HIV report experiencing and their scores on cognitive tests, measuring abilities such as memory and attention.
MedRisk, Inc., the workers' compensation industry leader in specialty managed care services, has announced the creation of its Risk Information and Business Intelligence (RIBI) unit. RIBI's first initiative is to roll out a new reporting platform featuring state-of-the-art graphics and outcomes analytics.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Edwin Peter Schulhafer, MD 712 Courtyard Dr, Hillsborough, NJ 08844-4257 Ph: (908) 252-1050 | Dr Edwin Peter Schulhafer, MD 712 Courtyard Dr, Hillsborough, NJ 08844-4257 Ph: (908) 252-1050 |
News Archive
Everyone knows olive oil and a Mediterranean diet are associated with a lower risk for cardiovascular disease, but a new research report published in the July 2010 print issue of the FASEB Journal offers a surprising reason why: These foods change how genes associated with atherosclerosis function.
UC San Francisco researchers have completed the first Internet-based clinical trial for children with autism, establishing it as a viable and cost effective method of conducting high-quality and rapid clinical trials in this population.
A new study shows that a drug, called daclizumab, is effective at reducing organ rejection and risk of infection in heart transplant patients. The multi-center study by cardiologists from the United States, Sweden, Germany and Canada will be published in the June 30 issue of The New England Journal of Medicine.
A new study has drawn a direct link between the amount of stigma men with HIV report experiencing and their scores on cognitive tests, measuring abilities such as memory and attention.
MedRisk, Inc., the workers' compensation industry leader in specialty managed care services, has announced the creation of its Risk Information and Business Intelligence (RIBI) unit. RIBI's first initiative is to roll out a new reporting platform featuring state-of-the-art graphics and outcomes analytics.
› Verified 4 days ago